CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Material agreement · Agreement ended
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- 4 Open-market sale General Counsel sold 1,956 shares at $18.91 ($36,988)
- 4 Open-market sale Chief Financial Officer sold 2,157 shares at $18.91 ($40,789)
- 4 Open-market sale Chief Business Officer sold 1,718 shares at $18.91 ($32,487)
- 4 Open-market sale Chief Scientific Officer sold 1,576 shares at $18.91 ($29,802)
- 4 Open-market sale CMO sold 3,682 shares at $18.91 ($69,627)
- 4 Open-market sale President and CEO sold 3,152 shares at $18.91 ($59,604)
Page 10 of 22 · 423 filings